Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma - Trial NCT06248840
Access comprehensive clinical trial information for NCT06248840 through Pure Global AI's free database. This phase not specified trial is sponsored by Zeng Changhao and is currently Terminated. The study focuses on Nasopharyngeal Carcinoma. Target enrollment is 56 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Zeng Changhao
People's Hospital of Zhengzhou University
Timeline & Enrollment
N/A
Jun 01, 2022
Dec 31, 2022
Primary Outcome
Hemoglobin,Serum albumin,Total serum protein,Serum prealbumin,Body Mass Index
Summary
This is a prospective multicenter study with patients with delayed dysphagia after
 radiotherapy for NPC. Patients enrolled are randomly divided equally into the observation
 group and the control group. All patients receive conventional care, and the observation
 group received IOE while the control group received NGT for enteral nutrition support.
 Baseline information (demographics, medical history, etc.), nutritional status at admission
 and after treatment, depression, dysphagia, and quality of life (QOL) after treatment as well
 as adverse events are compared.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06248840
Device Trial